Neuralink has received the green light to initiate recruitment for its inaugural human clinical trial, dubbed the PRIME Study (Precise Robotically Implanted Brain-Computer Interface).
The Pentagon's Defense Intelligence Agency’s National Center for Medical Intelligence (NCMI) unveiled that certain characteristics of the virus, SARS-CoV-2, indicate bioengineering.
Johnson stated, “These statements reveal an attempt to limit public access to certain communications directly related to the COVID-19 pandemic, potentially in violation of federal record keeping requirements.”
